Feedback Plc · LSE:FDBK

Feedback — H1 2026 Earnings Presentation

7 slides from Feedback's earnings presentation, February 2026

  1. Slide 1: Connectivity that liberates healthcare

    Connectivity that liberates healthcare Investor presentation Results for the 6 months ending 30th November 2025 Bleepa is a product by Feedback Medical | Feedback plc is a company registered in England and Wales Reg No: 00598696 | Reg Office: 201 Temple Chambers 3-7 Temple Avenue, London, EC4Y 0DT

  2. Slide 2: Disclaimer

    Disclaimer The information contained in this confidential document (the “Presentation”) and any information disclosed in any oral presentation thereof has been prepared by Feedback plc (the “Company”). It has not been fully verified and is subject to material updating, revision and further amendment

  3. Slide 3: Financial highlights

    FEEDBACK PLC INVESTOR PRESENTATION INTERIM RESULTS 2026 Financial highlights (all figures in £million) Revenue & Sales EBITDA loss Revenue: £0.41m (2025: £0.45m), down 8%. H1 25 included non- recurring revenue from CDC pilot contracts. Bleepa® contributed 89% (2025: 90%) (£1.61) (£1.43) Sales(1): £0

  4. Slide 4: Operational highlights

    FEEDBACK PLC INVESTOR PRESENTATION INTERIM RESULTS 2026 Operational highlights 1 A national business case for Bleepa was submitted as part of the Spending Review in the Spring – outcome pending 2 Integrations into eRS, PDS and GP Connect were completed (Implemented post period) - positions Feedback

  5. Slide 5: Driving productivity: asynchronous working

    FEEDBACK PLC INVESTOR PRESENTATION INTERIM RESULTS 2026 Driving productivity: asynchronous working Win – win for all parties: for ICBs, NHS Trusts and patients • Pathways delivered on average 63% faster than the 18-week national elective target • Traditional outpatient appointments reduced by 90% 5

  6. Slide 6: Outlook

    FEEDBACK PLC INVESTOR PRESENTATION INTERIM RESULTS 2026 Outlook Potential central opportunity following discussion with National Execs and Spending Review submission, outcome due in the spring 1 - Opportunity for national contract New money coming online from April with a focus on digital and produc

  7. Slide 7: NHS emerging from consolidation with commitment to tech

    FEEDBACK PLC INVESTOR PRESENTATION INTERIM RESULTS 2026 NHS emerging from consolidation with commitment to tech March 2025 - June 2025 - Restructuring Spending Review Feb 2026 • Announcement April 2027 that NHSE is to • Long-term Sept 2025 • NHSE/DHSC be abolished spending and merged • DHSC/NHSE Mer

Feedback — H1 2026 Earnings Presentation on 6ix